-
SAB Biotherapeutics to Host Virtual R&D Day on October 13, 2021
Registration Link Sioux Falls, S.D., October 6, 2021 – SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy…
-
SAB Biotherapeutics Announces First Patient Dosed in Phase 3 NIH ACTIV-2 Trial Evaluating SAB-185 for Treatment of COVID-19
Sioux Falls, S.D., October 4, 2021 – SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that…
-
SAB Biotherapeutics Appoints Russell Beyer Chief Financial Officer
SIOUX FALLS, S.D., September 28, 2021 – SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that…
-
SAB Biotherapeutics Announces SAB-185 Receives Positive DSMB Review and Advances to Phase 3 in NIH-Sponsored ACTIV-2 Trial for Treatment of COVID-19
Advancement to Phase 3 is major milestone for SAB’s unique DiversitAbTM immunotherapy platform that produces fully-human polyclonal antibodies without…
-
Big Cypress Acquisition Corp Announces Special Meeting of Stockholders to Approve Business Combination with SAB Biotherapeutics
Registration Statement on Form S-4 Has Been Declared Effective by Securities and Exchange Commission Stockholder Vote Scheduled for October 20, 2021…
-
SAB Biotherapeutics Announces Completion of Enrollment in Phase 2a Challenge Trial of SAB-176 for the Treatment of Seasonal Influenza
Topline data expected in 4Q2021 SIOUX FALLS, S.D., September 15, 2021 – SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a…
-
Cows Help With COVID-19 Treatment, No Bull
June 17, 2020 5:00 AM ET | Joe Palca It turns out, cows may play an important role in responding to the COVID-19 pandemic. SAB Biotherapeutics is in the…
-
Human Trials Expected To Start Next Month For Covid-19 Treatment Derived From Cows’ Blood
By Elizabeth Cohen, CNN Senior Medical Correspondent | Updated 10:41 PM ET, Tue June 16, 2020 (CNN) A South Dakota company expects to start human trials…
-
This Cow’s Antibodies Could Be The Newest Weapon Against COVID-19
By Mitch Leslie Jun. 5, 2020 , 4:35 PM Science’s COVID-19 reporting is supported by the Pulitzer Center. The latest recruits in the fight against…
-
Researchers Use Cows To Develop Antibody Treatment
Scientists at SAb Biotherapeutics are planning to start studies this summer on coronavirus treatments created by using antibodies derived from cows with…
-
I Am BIO | “Herd” Immunity Podcast
Biotech companies are working feverishly to develop antibody therapies to provide short-term protection against COVID-19. But what if the novel…